[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
March 18, 1998

Methotrexate Errors

Author Affiliations
 

Not Available

Not Available

JAMA. 1998;279(11):818. doi:10.1001/jama.279.11.818-JHA80001-4-1

Medication errors involving the use of the powerful cytotoxic agent methotrexate have resulted in serious harm to patients, including death, according to the US Pharmacopeia (USP) Medication Errors Reporting Program.

Since 1991, the program has received more than a dozen reports of errors in dosing, directions for use, and order interpretation involving methotrexate. In 1 case, a 20-year-old patient with renal failure died within 2 weeks after taking methotrexate that a pharmacist dispensed instead of metolazone. In another instance, a patient being treated for psoriasis was hospitalized and eventually died after taking methotrexate every 12 hours for 6 consecutive days instead of every 12 hours for 3 doses each week as instructed.

First Page Preview View Large
First page PDF preview
First page PDF preview
×